期刊文献+

人骨骼肌源性血管外膜细胞对人脐血CD34^+细胞的体外造血支持作用 被引量:3

In vitro hematopoietic support of human umbilical cord blood CD34^+ cells by human skeletal muscle-derived pericytes/perivascular cells
下载PDF
导出
摘要 背景:研究显示血管外膜细胞是间充质干细胞的前体细胞,其通过细胞接触或旁分泌效应调节造血干细胞的行为并支持造血,人骨骼肌源性血管外膜细胞对造血的支持作用有待于研究。目的:从人骨骼肌中分离培养血管外膜细胞并进行生物学特性鉴定,研究其对脐血CD34^+细胞的体外支持作用。方法:①利用多参数流式细胞术从人骨骼肌中分选表型为CD146^+CD56^-CD34^-CD144^-CD45^-的血管外膜细胞,并对其进行生物学鉴定;②建立以CD146^+人骨骼肌源性血管外膜细胞为滋养层的脐血CD34^+细胞体外培养体系(实验组),以人骨髓间充质干细胞为滋养层的脐血CD34^+细胞体外培养体系为阳性对照组,共培养1,2,4周检测培养体系的细胞数量、集落形成能力及免疫表型并进行统计分析。结果与结论:①通过多参数流式细胞术分选出CD146+人骨骼肌源性血管外膜细胞,回测纯度为(91.5±1.85)%(n=5);其表达间充质干细胞表面抗原CD73、CD90、CD105、CD44,不表达造血细胞及内皮细胞表面抗原CD45、CD34、CD31;经诱导培养可向骨细胞、软骨细胞、脂肪细胞及肌细胞分化;②实验组与阳性对照组相比,在细胞数、集落形成能力及免疫表型方面(CD45^+、CD34^+CD33^-、CD14^+、CD10^+/CD19)差异均无显著性意义(P> 0.05,n=6);无滋养层的空白对照组培养1周时细胞数量明显减少,2周时几乎无细胞存活;③结果表明,CD146^+人骨骼肌源性血管外膜细胞与人骨髓间充质干细胞一样对脐血CD34^+细胞具有体外支持作用。 BACKGROUND: Perivascular cells have been shown to be the precursor cells of mesenchymal stem cells, which regulate the behavior of hematopoietic stem cells and support hematopoiesis through cell-to-cell contact or paracrine effects. Hematopoietic support of human skeletal muscle-derived pericytes/perivascular cells(hMD-PCs) remains to be studied. OBJECTIVE: To identify the biological characteristics of hMD-PCs isolated from human skeletal muscle and to study their supporting effect on umbilical cord blood CD34^+ cells in vitro. METHODS:(1) hMD-PCs with phenotype CD146^+CD56^-CD34^-CD144^-CD45^-were sorted from human skeletal muscle by enzymatic digestion and multiparameter fluorescence-activated cell sorting, and their biological characteristics were identified.(2) The in vitro culture system of umbilical cord blood CD34^+ cells co-cultured with human CD146^+ hMD-PCs(experimental group) or with human bone marrow mesenchymal stem cells(positive control group) was established. After 1, 2 and 4 weeks of co-culture, the number of cells, the colony formation ability and immunophenotype were measured and statistically analyzed. RESULTS AND CONCLUSION:(1) CD146^+ hMD-PCs were sorted by multiparameter fluorescence-activated cell sorting and the purity was(91.5±1.85)%(n=5). CD146+ hMD-PCs expressed mesenchymal surface markers CD73, CD90, CD105, CD44, and did not express hematopoietic cell and endothelial cell markers CD45, CD34, and CD31. After induced culture, CD146+ hMD-PCs could differentiate into osteoblasts, chondrogenesis, adipocytes and myoblasts.(2) There were no significant differences in the cell number, colony formation ability or immunophenotype(CD45^+, CD34^+CD33^-, CD14^+, CD10^+/CD19^+) between experimental and positive control groups(P > 0.05, n=6). The number of cells in the blank control group without feeder was significantly decreased at 1 week of culture, and there was almost no cell survival at 2 weeks of culture.(3) In summary, CD146^+ hMD-PCs, like human bone marrow mesenchymal stem cells, have hematopoietic support capacity in vitro.
作者 杨小萍 杨婷婷 古晶晶 周芮 许飞 杨继辉 郑波 Yang Xiaoping;Yang Tingting;Gu Jingjing;Zhou Rui;Xu Fei;Yang Jihui;Zheng Bo(Ningxia Medical University,Yinchuan 750004,Ningxia Hui Autonomous Region,China;Human Stem Cell Institute,General Hospital of Ningxia Medical University,Yinchuan 750004,Ningxia Hui Autonomous Region,China;Department of Hematology,General Hospital of Ningxia Medical University,Yinchuan 750004,Ningxia Hui Autonomous Region,China)
出处 《中国组织工程研究》 CAS 北大核心 2020年第13期2047-2054,共8页 Chinese Journal of Tissue Engineering Research
基金 国家自然科学基金(81560023),项目负责人:郑波~~
关键词 人骨骼肌源性血管外膜细胞 脐血CD34+细胞 人骨髓间充质干细胞 滋养层 体外支持 human skeletal muscle-derived pericytes/perivascular cells umbilical cord blood CD34+ cells human bone marrow mesenchymal stem cells trophoderm in vitro support
  • 相关文献

参考文献8

二级参考文献100

  • 1吕璐璐,刘拥军,许贞书,王彤,张浪辉,朱雄鹏,梁琳慧,王晗,陈志哲,韩忠朝.脐带源间充质干细胞的分离和生物学性状[J].福建医科大学学报,2006,40(2):99-104. 被引量:38
  • 2岑洪,林茂芳.脐带血造血前体细胞在间质干细胞微环境中的增殖和分化特性研究[J].中国病理生理杂志,2007,23(5):995-998. 被引量:3
  • 3姚雯(综述),孙自敏(审校).脐带血干/祖细胞的体外扩增实验研究进展[J].国际儿科学杂志,2007,34(3):202-205. 被引量:2
  • 4Robinson SN,Ng J,Niu T,et al.Superior ex-vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cell[J].Bone Marrow Transplant,2006,37(4):359.
  • 5Angelopoulou M,Novelli E,Grove JE,et al.Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice.Exp Hematol.2003;31(5):413-420.
  • 6Deans RJ,Moselay AB.Mesenchymal stem cells:biology and potential clinical uses.Exp Hematol 2000;28(8):875-884.
  • 7Le Blanc K,Ringden O.Mesenchymal stem cells:properties and role in clinical bone marrow transplantation.Cur Opin Immunol 2006;18(5):586-591.
  • 8Lu LL,Liu YJ,Yang SG,et al.lsolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials.Haematologica 2006;91(8):1017-1026.
  • 9D'lppolito G,Schiller PC,Ricordi C,et al.Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow.J Bone Miner Res 1999;14(7):1115-1122.
  • 10D'lppolito G,Howard GA,Roos BA,et al.Sustained stromal stem cell self-renewal and osteoblastic difrerentiation during aging.Rejuv Res.2006;9(1):10-19.

共引文献22

同被引文献32

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部